{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:11:09Z","timestamp":1770145869159,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,10,1]],"date-time":"1993-10-01T00:00:00Z","timestamp":749433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1993,10,1]],"date-time":"1993-10-01T00:00:00Z","timestamp":749433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1993,10]]},"DOI":"10.1007\/bf02260922","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T02:54:14Z","timestamp":1132714454000},"page":"199-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Substance P receptors are differentially affected in Parkinson's and Alzheimer's disease"],"prefix":"10.1007","volume":"6","author":[{"given":"L.","family":"Rioux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1993,10,1]]},"reference":[{"issue":"10","key":"BF02260922_CR1","first-page":"366","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. TINS 12(10): 366\u2013375","journal-title":"TINS"},{"issue":"6","key":"BF02260922_CR2","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1111\/j.1471-4159.1988.tb02497.x","volume":"50","author":"DM Araujo","year":"1988","unstructured":"Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50(6): 1914\u20131923","journal-title":"J Neurochem"},{"issue":"0","key":"BF02260922_CR3","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1523\/JNEUROSCI.11-08-02332.1991","volume":"11","author":"C Arenas","year":"1991","unstructured":"Arenas C, Alberch J, Perez-Navarro E, Salsona C, Marsal J (1991) Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J Neurosci 11(0): 2332\u20132338","journal-title":"J Neurosci"},{"key":"BF02260922_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-0270(90)90139-7","volume":"32","author":"R Artymyshyn","year":"1990","unstructured":"Artymyshyn R, Smith A, Wolfe BB (1990) The use of3H standards in125I autoradiography. J Neurosci Methods 32: 185\u2013192","journal-title":"J Neurosci Methods"},{"key":"BF02260922_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0169-328X(87)90041-6","volume":"3","author":"MJ Bannon","year":"1987","unstructured":"Bannon MJ, Elliott PJ, Bunney EB (1987) Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Mol Brain Res 3: 31\u201337","journal-title":"Mol Brain Res"},{"key":"BF02260922_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0169-328X(92)90088-S","volume":"12","author":"MJ Bannon","year":"1992","unstructured":"Bannon MJ, Poosch MS, Haverstick DM, Mandal A, Xue IC-H, Shibata K, Dragovic LJ (1992) Preprotachykinin gene expression in the basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing. Mol Brain Res 12: 225\u2013231","journal-title":"Mol Brain Res"},{"key":"BF02260922_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1212\/WNL.37.7.1205","volume":"37","author":"MF Beal","year":"1987","unstructured":"Beal MF, Mazurek MF, Lorenz LJ (1987) Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology 37: 1205\u20131209","journal-title":"Neurology"},{"issue":"4","key":"BF02260922_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0306-4522(86)90105-3","volume":"18","author":"JC Beaujouan","year":"1986","unstructured":"Beaujouan JC, Torrens Y, Saffroy M, Glowinski J (1986) Quantitative autoradiographic analysis of the distribution of binding sites for [125I] Bolton Hunter derivatives of eledoisin and substance P in the rat brain. Neuroscience 18(4): 857\u2013875","journal-title":"Neuroscience"},{"key":"BF02260922_CR9","first-page":"65","volume":"7","author":"SH Buck","year":"1986","unstructured":"Buck SH, Burcher E (1986) A family of peptides with a brood of \u201creceptors\u201d. TPS 7: 65\u201368","journal-title":"TPS"},{"key":"BF02260922_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/0196-9781(86)90141-5","volume":"7","author":"SH Buck","year":"1986","unstructured":"Buck SH, Helke CJ, Burcher E (1986) Pharmacological characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides 7: 1109\u20131120","journal-title":"Peptides"},{"key":"BF02260922_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1440-1681.1989.tb01602.x","volume":"16","author":"E Burcher","year":"1988","unstructured":"Burcher E (1988) The study of tachikinin receptors. Clin Exp Pharmacol Physiol 16: 539\u2013543","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF02260922_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0006-8993(87)80024-0","volume":"410","author":"M-F Chesselet","year":"1987","unstructured":"Chesselet M-F, Affolter H-U (1987) Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain. Brain Res 410: 83\u201388","journal-title":"Brain Res"},{"key":"BF02260922_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0304-3940(89)90241-3","volume":"96","author":"M-F Chesselet","year":"1989","unstructured":"Chesselet M-F, Robbins E (1989) Regional differences in substance P-like immunoreactivity in the striatum correlate with levels of pre-protachykinin mRNA. Neurosci Lett 96: 47\u201353","journal-title":"Neurosci Lett"},{"key":"BF02260922_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0006-8993(89)90529-5","volume":"486","author":"RA Clevens","year":"1989","unstructured":"Clevens RA, Beal MF (1989) Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases. Brain Res 486: 387\u2013390","journal-title":"Brain Res"},{"issue":"2","key":"BF02260922_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0306-4522(89)90257-1","volume":"30","author":"CJ Cruz","year":"1989","unstructured":"Cruz CJ, Beckstead RM (1989) Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra. Neuroscience 30(2): 331\u2013338","journal-title":"Neuroscience"},{"key":"BF02260922_CR16","first-page":"831","volume":"12","author":"M Dietl","year":"1986","unstructured":"Dietl M, Probst A, Palacio JM (1986) Mapping of substance P receptor sites in the human brain: high densities in the substantia innominata and effect of senile dementia. Soc Neurosci Abstracts 12: 831","journal-title":"Soc Neurosci Abstracts"},{"key":"BF02260922_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0006-8993(89)90032-2","volume":"483","author":"M Dietl","year":"1989","unstructured":"Dietl M, Sanchez M, Probst A, Palacios M (1989) Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis. Brain Res 483: 39\u201349","journal-title":"Brain Res"},{"key":"BF02260922_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewick O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38: 1236\u20131239","journal-title":"Klin Wochenschr"},{"key":"BF02260922_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0304-3940(90)90187-E","volume":"120","author":"R Elde","year":"1990","unstructured":"Elde R, Schalling M, Caccatelli S, Nakanishi S, H\u00f6kfelt T (1990) Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors. Neurosci Lett 120: 134\u2013138","journal-title":"Neurosci Lett"},{"key":"BF02260922_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0306-4522(84)90294-X","volume":"13","author":"TF Freund","year":"1984","unstructured":"Freund TF, Powell J, Smith AD (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13: 1189\u20131215","journal-title":"Neuroscience"},{"key":"BF02260922_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0006-8993(91)90563-B","volume":"556","author":"CR Gerfen","year":"1991","unstructured":"Gerfen CR (1991) Substance P (neurokinin 1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res 556: 165\u2013170","journal-title":"Brain Res"},{"key":"BF02260922_CR22","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Enger TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429\u20131432","journal-title":"Science"},{"key":"BF02260922_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.410270511","volume":"27","author":"S Goto","year":"1990","unstructured":"Goto S, Hirano A, Matsumoto S (1990) Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in Parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases. Ann Neurol 27: 520\u2013527","journal-title":"Ann Neurol"},{"key":"BF02260922_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0197-4580(83)90002-7","volume":"4","author":"CG Gottfries","year":"1983","unstructured":"Gottfries CG, Adolfson R, Aquilonius SM, Carlson A, Eckern\u00e4s SA, Nordberg A, Oreland L, Svennerholm L, Wiberg Ao, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type (AD\/5DAT). Neurobiol Aging 4: 261\u2013271","journal-title":"Neurobiol Aging"},{"key":"BF02260922_CR25","first-page":"135","volume-title":"Neuropeptides in neurologic and psychiatric disease. Association for research in nervous and mental disease, vol 64","author":"AM Graybiel","year":"1986","unstructured":"Graybiel AM (1986) Neuropeptides in the basal ganglia. In: Martin JB, Barchas JD (eds) Neuropeptides in neurologic and psychiatric disease. Association for research in nervous and mental disease, vol 64. Raven Press, New York, pp 135\u2013161"},{"key":"BF02260922_CR26","first-page":"19","volume":"45","author":"O Hornykiewick","year":"1986","unstructured":"Hornykiewick O, Kish SJ (1986) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45: 19\u201334","journal-title":"Adv Neurol"},{"key":"BF02260922_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0014-4886(91)90016-6","volume":"113","author":"JN Joyce","year":"1991","unstructured":"Joyce JN (1991a) Differential response of striatal dopamine receptor subtypes and cholinergic muscarinic receptors to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Exp Neurol 113: 261\u2013276","journal-title":"Exp Neurol"},{"key":"BF02260922_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0014-4886(91)90017-7","volume":"113","author":"JN Joyce","year":"1991","unstructured":"Joyce JN (1991 b) Differential response of striatal dopamine receptor subtypes and cholinergic muscarinic receptors to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections in the VTA or reserpine treatment. Exp Neurol 113: 277\u2013290","journal-title":"Exp Neurol"},{"key":"BF02260922_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0006-8993(93)90414-I","volume":"600","author":"JN Joyce","year":"1993","unstructured":"Joyce JN (1993) Differential response of striatal dopamine receptor subtypes and cholinergic muscarinic receptors to the loss of dopamine. III. Effects in Parkinson's disease. Brain Res 600: 156\u2013160","journal-title":"Brain Res"},{"key":"BF02260922_CR30","first-page":"216","volume-title":"Methods in neurosciences, 7","author":"JN Joyce","year":"1991","unstructured":"Joyce JN, Hensler JG, Tejani-Butt SM (1991) Neurochemical lesioning techniques for assessing regulation of monoamine receptors. In: Conn PM (ed) Methods in neurosciences, 7. Academic Press, San Diego, pp 216\u2013240"},{"key":"BF02260922_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"ZS Katchaturian","year":"1985","unstructured":"Katchaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097\u20131105","journal-title":"Arch Neurol"},{"key":"BF02260922_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0006-8993(86)90820-6","volume":"37","author":"J-M Lee","year":"1986","unstructured":"Lee J-M, McLean S, Maggio JE, Zamir N, Roth RH, Eskay RL, Bannon MJ (1986) The localization and characterization of substance P and substance K in striatonigral neurons. Brain Res 37: 152\u2013154","journal-title":"Brain Res"},{"key":"BF02260922_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF00247354","volume":"74","author":"N Lindefors","year":"1989","unstructured":"Lindefors N, Brodin E, Tossman U, Segovia J, Ungersteadt U (1989) Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp Brain Res 74: 527\u2013534","journal-title":"Exp Brain Res"},{"issue":"3","key":"BF02260922_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/0306-4522(86)90041-2","volume":"17","author":"JK Mai","year":"1986","unstructured":"Mai JK, Stephens PH, Hoft A, Cuello AC (1986) Substance P in the human brain. Neuroscience 17(3): 709\u2013739","journal-title":"Neuroscience"},{"key":"BF02260922_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0006-8993(89)90586-6","volume":"485","author":"S Marakami","year":"1989","unstructured":"Marakami S, Kubota Y, Kito S, Shimada S, Takagi H, Wu J-Y, Inagaki S (1989) The coexistence of substance P- and glutamic acid decarboxylase-like immunoreactivity in entopeduncular neurons of the rat. Brain Res 485: 403\u2013406","journal-title":"Brain Res"},{"key":"BF02260922_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0006-8993(83)90403-1","volume":"268","author":"A Mauborgne","year":"1983","unstructured":"Mauborgne A, Javoy-Agid F, Legrand JC, Agid Y, Cesselin F (1983) Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res 268: 167\u2013170","journal-title":"Brain Res"},{"key":"BF02260922_CR37","first-page":"1260","volume":"21","author":"AM Murray","year":"1991","unstructured":"Murray AM, Weihmueller F, Marshall JF, Joyce JN (1991) Disturbances in pre- and postsynaptic dopamine systems in Parkinson's and Alzheimer's disease. Soc Neurosci Abstracts 21: 1260","journal-title":"Soc Neurosci Abstracts"},{"key":"BF02260922_CR38","first-page":"221","volume":"2","author":"BR Pearce","year":"1984","unstructured":"Pearce BR, Palmer AM, Bowen DM, Wilcock GK, Esiri MM, Davison AN (1984) Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. Neurochem Pathol 2: 221\u2013231","journal-title":"Neurochem Pathol"},{"key":"BF02260922_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0169-328X(92)90042-A","volume":"13","author":"AE Pollack","year":"1992","unstructured":"Pollack AE, Wooten GF (1992) D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Mol Brain Res 13: 35\u201341","journal-title":"Mol Brain Res"},{"key":"BF02260922_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(88)80061-7","volume":"9","author":"K Reinikainen","year":"1988","unstructured":"Reinikainen K, Paljarvi L, Haloen T, et al (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9: 245\u2013252","journal-title":"Neurobiol Aging"},{"key":"BF02260922_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0006-8993(78)90562-0","volume":"159","author":"TD Reisine","year":"1978","unstructured":"Reisine TD, Yamamura HI, Brid ED, Spokes E, Enna SJ (1978) Pre- and postsynaptic neurochemical alterations in Alzheimer's disease. Brain Res 159: 447\u2013481","journal-title":"Brain Res"},{"key":"BF02260922_CR42","first-page":"95","volume-title":"Atlas of the human brain in section","author":"SJ Roberts","year":"1971","unstructured":"Roberts SJ, Hanaway J (1971) Atlas of the human brain in section. Lea and Febiger, Philadelphia, p 95"},{"key":"BF02260922_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0006-8993(90)91561-T","volume":"521","author":"T Sakurada","year":"1990","unstructured":"Sakurada T, Alufuzoff I, Winblad B, Nordberg A (1990) Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multiinfarct dementia. Brain Res 521: 329\u2013332","journal-title":"Brain Res"},{"key":"BF02260922_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0143-4179(91)90148-C","volume":"18","author":"SP Sivam","year":"1991","unstructured":"Sivam SP (1991) Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains. Neuropeptides 18: 201\u2013207","journal-title":"Neuropeptides"},{"issue":"5","key":"BF02260922_CR45","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/j.1471-4159.1987.tb01036.x","volume":"49","author":"SP Sivam","year":"1987","unstructured":"Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong J-S (1987) Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J Neurochem 49(5): 1623\u20131633","journal-title":"J Neurochem"},{"key":"BF02260922_CR46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/0196-9781(82)90076-6","volume":"3","author":"CW Shults","year":"1982","unstructured":"Shults CW, Quirion R, Jensen RT, Moody TW, O'Donohue TL, Chase TN (1982) Autoradiographic localization of substance P receptors using125I substance P. Peptides 3: 1073\u20131075","journal-title":"Peptides"},{"key":"BF02260922_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(84)90285-3","volume":"323","author":"T Sugimoto","year":"1984","unstructured":"Sugimoto T, Takada M, Kaneko T, Mizuno N (1984) Substance P-sositive thalamocaudate neurons in the center median-parafascicular complex in the cat. Brain Res 323: 181\u2013184","journal-title":"Brain Res"},{"key":"BF02260922_CR48","first-page":"145","volume":"53","author":"O Tenovuo","year":"1990","unstructured":"Tenovuo O, Kolhinen O, Laihinen A, Rinne UK (1990) Brain substance P recetors in Parkinson's disease. Adv Neurol 53: 145\u2013148","journal-title":"Adv Neurol"},{"key":"BF02260922_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0006-8993(84)90217-8","volume":"303","author":"O Tenovuo","year":"1984","unstructured":"Tenovuo O, Rinne UK, Viljanen MK (1984) Substance P immunoreactivity in the post-mortem parkinsonian brain. Brain Res 303: 113\u2013116","journal-title":"Brain Res"},{"key":"BF02260922_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0022-510X(70)90063-8","volume":"11","author":"BE Tomlinson","year":"1970","unstructured":"Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205\u2013242","journal-title":"J Neurol Sci"},{"key":"BF02260922_CR51","doi-asserted-by":"publisher","first-page":"9827","DOI":"10.1073\/pnas.83.24.9827","volume":"83","author":"WS Young III","year":"1976","unstructured":"Young WS III, Bonner TI, Brann MR (1976) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83: 9827\u20139831","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02260922\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02260922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:03:11Z","timestamp":1750824191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02260922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,10]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,10]]}},"alternative-id":["BF02260922"],"URL":"https:\/\/doi.org\/10.1007\/bf02260922","relation":{},"ISSN":["0936-3076"],"issn-type":[{"value":"0936-3076","type":"print"}],"subject":[],"published":{"date-parts":[[1993,10]]},"assertion":[{"value":"5 March 1993","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 1993","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 1993","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}